The relationship between systolic blood pressure on admission and mortality in older patients with heart failure

European Journal of Heart Failure

Volumn 12, Issue 2, 2010, Pages 148-155

  Vidán, María T ^a   Bueno, Héctor ^a   Wang, Yongfei ^d   Schreiner, Geoffrey ^d,e   Ross, Joseph S ^b,c   Chen, Jersey ^d   Krumholz, Harlan M ^d,e  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e YALE NEW HAVEN HOSPITAL   (United States)

Author keywords

Heart failure; Mortality; Prediction; Systolic blood pressure

Indexed keywords

AGED; AGED HOSPITAL PATIENT; ARTICLE; DIASTOLIC BLOOD PRESSURE; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PULSE PRESSURE; SYSTOLIC BLOOD PRESSURE;

AGE FACTORS; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; CONFIDENCE INTERVALS; DIASTOLE; FEMALE; HEART FAILURE; HUMANS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; PATIENT ADMISSION; PROGNOSIS; RISK FACTORS; SPAIN; STATISTICS AS TOPIC; SYSTOLE;

EID: 75149118210     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfp195     Document Type: Article

References (29)

1. Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK. The progression from hypertension to congestive heart failure. J Am Med Assoc 1996;275:1557-1562. (Pubitemid 26154241)
2. Moser M, Hebert PR. Prevention od disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials. J Am Coll Cardiol 1996;27:1214-1218.
3. Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, Stoyanovsky V, Antikainen RL, Nikitin Y, Anderson C, Belhani A, Forette F, Rajkumar C, Thijs L, Banya W, Bulpitt CJ, HYVET Study Group. Treatment of hypertension in patients 80 of age or older. N Engl J Med 2008;358:1887-1898.
4. Bhatia RS, Tu JV, Lee DS, Austin PC, Fang J, Haouzi A, Gong Y, Liu PP. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 2006;355:260-269. (Pubitemid 44088349)
5. Fonarow GC, Adams KF Jr, Abraham WT, Yancy CW, Boscardin WJ. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. J Am Med Assoc 2005;293:572-580.
6. Gheorghiade M, Abraham WT, Albert NM, Greenberg BH, O'Connor CM, She L, Gattis Stough W, Yancy CW, Young JB, Fonarow GC, for the OPTIMIZE-HF Investigators Coordinators. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. J Am Med Assoc 2006;296:2217-2226.
7. Huynh BC, Rovner A, Rich MW. Long-term survival in elderly patients hospitalized for heart failure: 14-year follow-up from a prospective randomized trial. Arch Intern Med 2006;166:1892-1898.
8. Lee DS, Austin PC, Rouleau JL, Liu PP, Naimark D, Tu JV. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. J Am Med Assoc 2003;290:2581-2587.
9. Adams KF Jr, Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR, Abraham WT, Berkowitz RL, Galvao M, Horton DP. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute. Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2005;149:209-216
10. Ferdinand KC. Recommendations for the management of special populations: racial and ethnic populations. Am J Hypertens 2003;16:50S-54S.
11. Glynn RJ, L'Italien GJ, Sesso HD, Jackson EA, Buring JE. Development of predictive models for long-term cardiovascular risk associated with systolic and diastolic blood pressure. Hypertension 2002;39:105-110.
12. Oates DJ, Berlowitz DR, Glickman ME, Silliman RA, Borzecki AM. Blood pressure and survival in the oldest old. J Am Geriatr Soc 2007;55:383-388.
13. McMurray JJ, Carson PE, Komajda M, McKelvie R, Zile MR, Ptaszynska A, Staiger C, Donovan JM, Massie BM. Heart failure with preserved ejection fraction: clinical characteristics of 4133 patients enrolled in the I-PRESERVE trial. Eur J Heart Fail 2008;10:149-156.
14. Masoudi FA, Ordin DL, Delaney RJ, Krumholz HM, Havranek EP. The National Heart Failure Project: a Health Care Financing Administration initiative to improve the care of Medicare beneficiaries with heart failure. Congest Heart Fail 2000;6:337-339.
15. Cuffe MS, Califf RM, Adams KF Jr, Benza R, Bourge R, Colucci WS, Massie BM, O'Connor CM, Pina I, Quigg R, Silver MA, Gheorghiade M. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. J Am Med Assoc 2002;287:1541-1547. (Pubitemid 34269999)
16. Felker GM, O'Connor CM. Inotropic therapy for heart failure: an evidence-based approach. Am Heart J 2001;142:393-401.
17. Hauptman PJ, Mikolajczak P, George A, Mohr CJ, Hoover R, Swindle J, Schnitzler MA. Chronic inotropic therapy in end-stage heart failure. Am Heart J 2006;152:1096.e1-e1098.
18. Huynh BC, Rovner A, Rich MW. Identification of older patients with heart failure who may be candidates for hospice care: development of a simple four-item risk score. J Am Geriatr Soc 2008;56:1111-1115.
19. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;353:2001-2007.
20. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH, for the US Carvedilol Heart Failure Study Group. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med 1996;334:1349-1355.
21. CIBIS Investigators and Committees. A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation 1994;90: 1765-1773.
22. Gheorghiade M, Zannad F, Sopko G, Klein L, Piña IL, Konstam MA, Massie BM, Roland E, Targum S, Collins SP, Filippatos G, Tavazzi L. Acute heart failure syndromes: current state and framework for future research. Circulation 2005;112: 3958-3968. (Pubitemid 43739494)
23. Grigorian-Shamagian L, Gonzalez-Juanatey JR, Vazquez R, Cinca J, Bayes-Genis A, Pascual D, Fernández-Palomeque C, Bardaj́i A, Almendral J, Nieto V, Macaya C, Pavón-Jimenez R, Bayés de Luna A. Association of blood pressure and its evolving changes with the survival of patients with heart failure. J Card Fail 2008;14: 561-568.
24. Lee T, Chen J, Cohen DJ, Tsao L. The association between blood pressure and mortality in patients with heart failure. Am Heart J 2006;151:76-83.
25. Aronson D, Mittleman MA, Burger AJ. Elevated blood urea nitrogen level as a predictor of mortality in patients admitted for decompensated heart failure. Am J Med 2004;116:466-473.
26. Zannad F, Mebazaa A, Juilliere Y, Cohen-Solal A, Guize L, Alla F, Rouge P, Blin P, Barlet MH, Paolozzi L, Vincent C, Desnos M, Samii K. Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: the EFICA study. Eur J Heart Fail 2006;8:697-705.
27. Abraham WT, Fonarow GC, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, OConnor CM, Sun JL, Yancy CW, Young JB, on behalf of the OPTIMIZE-HF Investigators Coordinators. Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). J Am Coll Cardiol 2008;52:347-356. (Pubitemid 352005813)
28. Chae CU, Pfeffer MA, Glynn RJ, Mitchell GF, Taylor JO, Hennekens CH. Increased pulse pressure and risk of heart failure in the elderly. J Am Med Assoc 1999;281: 634-639.
29. Psaty BN, Boineau R, Kuller LH, Luepker RV. The potential costs of upcoding for heart failure in the United States. Am J Cardiol 1999;84:108-109.